@article{cf764398811d4c6ba5ee9637b2fe8635,
title = "Gynecomastia and hypertension in a patient treated with posaconazole",
abstract = "Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.",
keywords = "11beta-hydroxylase, adverse drug effect, estradiol, gynecomastia, hypertension, hypokalemia, posaconazole",
author = "Thompson, {George R.} and Surampudi, {Prasanth N.} and Alex Odermatt",
note = "Funding Information: This study was supported by funding from the University of California, Davis School of Medicine, Davis, USA (GRT), and the Swiss Centre for Applied Human Toxicology, Basel, Switzerland (AO). Funding Information: This study was supported by funding from the University of California, Davis School of Medicine, Davis, USA (GRT), and the Swiss Centre for Applied Human Toxicology, Basel, Switzerland (AO). Published with written consent of the patient. Publisher Copyright: {\textcopyright} 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd",
year = "2020",
month = dec,
doi = "10.1002/ccr3.3376",
language = "English (US)",
volume = "8",
pages = "3158--3161",
journal = "Clinical Case Reports",
issn = "2050-0904",
publisher = "John Wiley and Sons Ltd",
number = "12",
}